Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:methyllycaconitine
go back to main search page
Accession:CHEBI:43931 term browser browse the term
Definition:A diterpenoid that has formula C37H50N2O10.
Synonyms:alt_id: CHEBI:6880;   CHEBI:91631
 xref_mesh: MESH:C054634


show annotations for term's descendants           Sort by:
methyllycaconitine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKT1 AKT serine/threonine kinase 1 multiple interactions
increases phosphorylation		 EXP AKT1 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; methyllycaconitine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of and results in increased activity of AKT1 protein]
methyllycaconitine results in increased phosphorylation of AKT1 protein		 CTD PMID:12511591 PMID:24012499 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G APP amyloid beta precursor protein multiple interactions
decreases secretion		 ISO
EXP		 methyllycaconitine inhibits the reaction [Galantamine inhibits the reaction [APP protein modified form results in decreased expression of CHRNA7 protein]]; methyllycaconitine inhibits the reaction [N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide inhibits the reaction [APP protein modified form results in decreased expression of CHRNA7 protein]]
[APP protein co-treated with methyllycaconitine] results in decreased secretion of APP protein
methyllycaconitine results in decreased secretion of APP protein		 CTD PMID:25881725 PMID:29341888 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128 		JBrowse link
G BDNF brain derived neurotrophic factor multiple interactions EXP methyllycaconitine inhibits the reaction [Nicotine results in increased secretion of BDNF protein] CTD PMID:16790237 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058 		JBrowse link
G CASP3 caspase 3 multiple interactions ISO methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein]] CTD PMID:26286524 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CD36 CD36 molecule (CD36 blood group) multiple interactions ISO methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of CD36 protein] CTD PMID:28202387 NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277 		JBrowse link
G CDH5 cadherin 5 multiple interactions EXP methyllycaconitine inhibits the reaction [Varenicline results in decreased expression of CDH5] CTD PMID:28842382 NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784 		JBrowse link
G CHAT choline O-acetyltransferase multiple interactions EXP methyllycaconitine inhibits the reaction [SLURP1 protein results in increased expression of CHAT] CTD PMID:24365495 NCBI chr10:49,609,095...49,667,942
Ensembl chr10:49,609,095...49,667,942 		JBrowse link
G CHRNA2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO methyllycaconitine affects binding competes with [Epibatidine binds to Chrna2 protein] RGD PMID:15016836 RGD:2303194 NCBI chr 8:27,459,756...27,479,261
Ensembl chr 8:27,459,756...27,479,883 		JBrowse link
G CHRNA3 cholinergic receptor nicotinic alpha 3 subunit affects response to substance
multiple interactions		 ISO CHRNA3 protein affects the susceptibility to methyllycaconitine
methyllycaconitine affects binding [Epibatidine binds to Chrna3 protein]		 CTD
RGD		 PMID:19098233 PMID:15016836 RGD:2303194 NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295 		JBrowse link
G CHRNA4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions
affects activity		 EXP
ISO		 Carbachol inhibits the reaction [methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
methyllycaconitine affects the activity of CHRNA4 protein
methyllycaconitine affects binding to Chrna4 protein; methyllycaconitine competes with [Epibatidine binds to Chrna4 protein]		 CTD
RGD		 PMID:14645658 PMID:19047205 PMID:15016836 RGD:2303194 NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401 		JBrowse link
G CHRNA5 cholinergic receptor nicotinic alpha 5 subunit affects response to substance ISO CHRNA5 protein affects the susceptibility to methyllycaconitine CTD PMID:19098233 NCBI chr15:78,565,520...78,595,269
Ensembl chr15:78,565,520...78,595,269 		JBrowse link
G CHRNA7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions
affects binding
affects response to substance		 EXP
ISO		 [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased abundance of Epinephrine]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased expression of DBH mRNA]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased expression of TH mRNA]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGA2B mRNA; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGA2B protein; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGB3 mRNA; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGB3 protein; [methyllycaconitine binds to and results in increased activity of CHRNA7 protein] which results in increased transport of Calcium; methyllycaconitine binds to and results in decreased activity of CHRNA7 protein; methyllycaconitine binds to and results in increased activity of CHRNA7 protein; methyllycaconitine inhibits the reaction [[[1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea affects the activity of CHRNA7 protein] co-treated with [PNU-282987 binds to and results in increased activity of CHRNA7 protein]] results in increased uptake of Calcium]; methyllycaconitine inhibits the reaction [Bungarotoxins binds to CHRNA7 protein]; methyllycaconitine inhibits the reaction [Choline results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [desnitroimidacloprid results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [epibatidine binds to CHRNA7 protein]; methyllycaconitine inhibits the reaction [Nicotine binds to and results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [PNU-282987 binds to and results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [pozanicline binds to and results in increased activity of CHRNA7 protein]; methyllycaconitine promotes the reaction [[Nicotine results in increased activity of CHRNA7 protein] which results in increased transport of Calcium]
methyllycaconitine analog binds to CHRNA7 protein; methyllycaconitine binds to CHRNA7 protein
[methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which affects the susceptibility to Nicotine; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased susceptibility to bis(12)-hupyridone; methyllycaconitine binds to and results in decreased activity of CHRNA7 protein; methyllycaconitine inhibits the reaction [[3-(4-hydroxy-2-methoxybenzylidene)anabaseine co-treated with 5-hydroxyindole] results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [Acetylcholine results in increased activity of CHRNA7 protein]; methyllycaconitine inhibits the reaction [iodo-alpha-bungarotoxin binds to CHRNA7 protein]; methyllycaconitine inhibits the reaction [Melitten results in increased activity of CHRNA7 protein]; Nicotine inhibits the reaction [methyllycaconitine binds to CHRNA7 protein]
[methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased susceptibility to Nicotine; methyllycaconitine binds to and results in decreased activity of CHRNA7 protein; methyllycaconitine inhibits the reaction [Galantamine inhibits the reaction [APP protein modified form results in decreased expression of CHRNA7 protein]]; methyllycaconitine inhibits the reaction [N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide inhibits the reaction [APP protein modified form results in decreased expression of CHRNA7 protein]]
CHRNA7 protein affects the susceptibility to methyllycaconitine		 CTD PMID:9336329 PMID:10082212 PMID:10216184 PMID:11893908 PMID:12626641 More... NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018 		JBrowse link
G CHRNA9 cholinergic receptor nicotinic alpha 9 subunit multiple interactions EXP methyllycaconitine binds to and results in decreased activity of CHRNA9 protein CTD PMID:25282151 NCBI chr 4:40,335,333...40,355,217
Ensembl chr 4:40,335,333...40,355,217 		JBrowse link
G CHRNB2 cholinergic receptor nicotinic beta 2 subunit multiple interactions EXP
ISO		 Carbachol inhibits the reaction [methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
methyllycaconitine affects binding to Chrnb2 protein; methyllycaconitine competes with [Epibatidine binds to Chrnb2 protein]		 CTD
RGD		 PMID:14645658 PMID:15016836 RGD:2303194 NCBI chr 1:154,567,778...154,580,013
Ensembl chr 1:154,567,778...154,580,013 		JBrowse link
G DBH dopamine beta-hydroxylase multiple interactions EXP [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased expression of DBH mRNA] CTD PMID:17498763 NCBI chr 9:133,636,363...133,659,329
Ensembl chr 9:133,636,363...133,659,329 		JBrowse link
G H2AX H2A.X variant histone multiple interactions EXP methyllycaconitine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AX protein] CTD PMID:34784199 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465 		JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO methyllycaconitine inhibits the reaction [N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide inhibits the reaction [Estradiol affects the expression of IL1B mRNA]] CTD PMID:27766701 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 multiple interactions ISO methyllycaconitine affects the reaction [Nicotine results in increased expression of IL1R1 mRNA]; methyllycaconitine affects the reaction [Nicotine results in increased expression of IL1R1 protein] CTD PMID:27180639 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G IL6 interleukin 6 increases expression ISO methyllycaconitine results in increased expression of IL6 protein CTD PMID:25396421 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G ITGA2B integrin subunit alpha 2b multiple interactions EXP [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGA2B mRNA; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGA2B protein CTD PMID:21385097 NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649 		JBrowse link
G ITGAM integrin subunit alpha M multiple interactions ISO methyllycaconitine inhibits the reaction [4-naphthalene-1-yl-3a,4,5,9b-tetrahydro-3-H-cyclopenta(c)quinoline-8-sulfonic acid amide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of ITGAM mRNA]] CTD PMID:28867753 NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892 		JBrowse link
G ITGB3 integrin subunit beta 3 multiple interactions EXP [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGB3 mRNA; [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] which results in decreased expression of ITGB3 protein CTD PMID:21385097 NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation		 EXP
ISO		 [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; MAPK1 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK1 protein]
methyllycaconitine results in increased phosphorylation of MAPK1 protein		 CTD PMID:18448488 PMID:24012499 PMID:28202387 PMID:28842382 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation		 EXP
ISO		 [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; MAPK3 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of MAPK3 protein]
methyllycaconitine results in increased phosphorylation of MAPK3 protein		 CTD PMID:18448488 PMID:24012499 PMID:28202387 PMID:28842382 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MARCKS myristoylated alanine rich protein kinase C substrate increases phosphorylation EXP methyllycaconitine results in increased phosphorylation of MARCKS protein CTD PMID:24012499 NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475 		JBrowse link
G MKI67 marker of proliferation Ki-67 multiple interactions ISO methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein] CTD PMID:29501575 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423 		JBrowse link
G MTOR mechanistic target of rapamycin kinase increases phosphorylation
multiple interactions		 EXP methyllycaconitine results in increased phosphorylation of MTOR protein
MTOR mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]		 CTD PMID:24012499 NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556 		JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 multiple interactions ISO methyllycaconitine analog inhibits the reaction [Nicotine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 promotes the reaction [RELA protein binds to NFKB1 protein]]] CTD PMID:27984197 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302 		JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions ISO methyllycaconitine inhibits the reaction [4-naphthalene-1-yl-3a,4,5,9b-tetrahydro-3-H-cyclopenta(c)quinoline-8-sulfonic acid amide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NFKBIA mRNA]] CTD PMID:28867753 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NTRK2 neurotrophic receptor tyrosine kinase 2 multiple interactions EXP methyllycaconitine inhibits the reaction [Nicotine results in increased expression of NTRK2 protein] CTD PMID:16790237 NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751 		JBrowse link
G OLR1 oxidized low density lipoprotein receptor 1 multiple interactions ISO methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 mRNA]; methyllycaconitine inhibits the reaction [Varenicline results in increased expression of OLR1 protein] CTD PMID:28202387 NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO methyllycaconitine inhibits the reaction [Varenicline results in increased phosphorylation of RELA protein]
methyllycaconitine analog inhibits the reaction [Nicotine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 promotes the reaction [RELA protein binds to NFKB1 protein]]]		 CTD PMID:27984197 PMID:28202387 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G SLURP1 secreted LY6/PLAUR domain containing 1 multiple interactions EXP methyllycaconitine inhibits the reaction [SLURP1 protein results in increased abundance of Acetylcholine]; methyllycaconitine inhibits the reaction [SLURP1 protein results in increased expression of CHAT] CTD PMID:24365495 NCBI chr 8:142,740,949...142,742,406
Ensembl chr 8:142,740,949...142,742,406 		JBrowse link
G SRR serine racemase multiple interactions
increases expression		 EXP
ISO		 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; [methyllycaconitine co-treated with Egtazic Acid] results in increased expression of SRR protein; AKT1 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; Cycloheximide inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; MAPK1 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; MAPK3 mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; MTOR mutant form inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; Sirolimus inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]; U 0126 inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]
[methyllycaconitine co-treated with Egtazic Acid] results in increased expression of SRR protein; Cycloheximide inhibits the reaction [methyllycaconitine results in increased expression of SRR protein]		 CTD PMID:24012499 NCBI chr17:2,303,378...2,325,264
Ensembl chr17:2,303,383...2,325,260 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 multiple interactions
decreases phosphorylation		 EXP
ISO		 [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]
methyllycaconitine results in decreased phosphorylation of STAT3 protein
methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of STAT3 protein modified form]		 CTD PMID:18448488 PMID:25396421 PMID:29501575 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568 		JBrowse link
G TACR1 tachykinin receptor 1 multiple interactions ISO methyllycaconitine inhibits the reaction [Nicotine results in increased expression of TACR1 mRNA]; methyllycaconitine inhibits the reaction [Nicotine results in increased expression of TACR1 protein] CTD PMID:26524655 NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520 		JBrowse link
G TH tyrosine hydroxylase multiple interactions EXP [methyllycaconitine binds to and results in decreased activity of CHRNA7 protein] inhibits the reaction [Nicotine results in increased expression of TH mRNA] CTD PMID:17498763 NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815 		JBrowse link
G TNF tumor necrosis factor multiple interactions
increases expression		 EXP
ISO		 methyllycaconitine inhibits the reaction [Nicotine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF mRNA]]
methyllycaconitine results in increased expression of TNF protein		 CTD PMID:21606497 PMID:25396421 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TRPV1 transient receptor potential cation channel subfamily V member 1 multiple interactions ISO methyllycaconitine inhibits the reaction [Nicotine results in increased expression of TRPV1 mRNA]; methyllycaconitine inhibits the reaction [Nicotine results in increased expression of TRPV1 protein] CTD PMID:26524655 NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411 		JBrowse link
G TXN thioredoxin multiple interactions ISO methyllycaconitine inhibits the reaction [Nicotine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of TXN1 protein]]; methyllycaconitine inhibits the reaction [Nicotine results in increased expression of TXN1 protein] CTD PMID:28082123 NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507 		JBrowse link
G ZFP36 ZFP36 ring finger protein multiple interactions EXP methyllycaconitine inhibits the reaction [[Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA] CTD PMID:21606497 NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,407 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26089
    role 26005
      biological role 25984
        biochemical role 25213
          metabolite 25143
            alkaloid 8071
              terpene alkaloid 511
                diterpene alkaloid 509
                  methyllycaconitine 41
Path 2
Term Annotations click to browse term
  CHEBI ontology 26089
    subatomic particle 26064
      composite particle 26064
        hadron 26064
          baryon 26064
            nucleon 26016
              atomic nucleus 26064
                atom 26064
                  main group element atom 25891
                    main group molecular entity 25891
                      s-block molecular entity 25200
                        hydrogen molecular entity 24793
                          hydrides 22993
                            organic hydride 21950
                              organic fundamental parent 21950
                                hydrocarbon 21374
                                  terpene 14726
                                    terpenoid 14365
                                      diterpenoid 13529
                                        diterpene alkaloid 509
                                          aconitane 497
                                            methyllycaconitine 41
paths to the root